Drug Development
"Growth Inhibition of Mycobacterium tuberculosis and Mycobacterium avium by Plant Compounds and Extracts."
Published in TB and Outbreaks Week, July 24th, 1995
According to an abstract submitted by the authors to the 95th General Meeting of the American Society for Microbiology, held May 21-25, 1995, in Washington, D.C., "Due to re-emergence of tuberculosis, especially multi-drug resistant type, and high incidence of M. avium infection in AIDS patients, new and more effective antimycobacterial drugs are needed to treat these infections. We studied the effect of 9 compounds and extracts of plants on growth of type strains of M. tuberculosis (TB) and M. avium (MA). Growth inhibition was determined with the BACTEC Radiometric System which measures growth by detecting 14CO2 levels as a metabolic of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Occupational Risk
Assessing CDC TB Guidelines Impossible in Some Settings - Drug Resistance
New Cases of MDR-TB Come from Already Resistant Strains - Epidemiology
TB Rise in England/Wales Mostly Among Women - Infection Control
Modified BACTEC Useful in M. TB Disinfectant Testing - Opportunistic Infections
Rare Lung Ailment Becoming Common in AIDS Patients - Prisons
Health Board Goes to Feds Over Michigan Prison's "Mishandling" of TB - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
